BR112023019488A2 - Colágeno tipo ii recombinante para uso terapêutico - Google Patents

Colágeno tipo ii recombinante para uso terapêutico

Info

Publication number
BR112023019488A2
BR112023019488A2 BR112023019488A BR112023019488A BR112023019488A2 BR 112023019488 A2 BR112023019488 A2 BR 112023019488A2 BR 112023019488 A BR112023019488 A BR 112023019488A BR 112023019488 A BR112023019488 A BR 112023019488A BR 112023019488 A2 BR112023019488 A2 BR 112023019488A2
Authority
BR
Brazil
Prior art keywords
collagen
recombinant type
therapeutic use
therapeutic
recombinant
Prior art date
Application number
BR112023019488A
Other languages
English (en)
Inventor
Hans-Ulrich Frech
Martin Hahn
Steffen Oesser
Stephan Hausmanns
Original Assignee
Gelita Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gelita Ag filed Critical Gelita Ag
Publication of BR112023019488A2 publication Critical patent/BR112023019488A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

colágeno tipo ii recombinante para uso terapêutico. a presente invenção se refere a colágeno tipo ii recombinante, em particular, não desnaturado, para uso em um método terapêutico para terapia oral de doença da cartilagem de um paciente humano ou animal.
BR112023019488A 2021-03-23 2022-03-23 Colágeno tipo ii recombinante para uso terapêutico BR112023019488A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102021202830.6A DE102021202830A1 (de) 2021-03-23 2021-03-23 Rekombinantes Typ II-Kollagen zur therapeutischen Verwendung
PCT/EP2022/057624 WO2022200422A1 (de) 2021-03-23 2022-03-23 Rekombinantes typ ii-kollagen zur therapeutischen verwendung

Publications (1)

Publication Number Publication Date
BR112023019488A2 true BR112023019488A2 (pt) 2023-10-31

Family

ID=81388936

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023019488A BR112023019488A2 (pt) 2021-03-23 2022-03-23 Colágeno tipo ii recombinante para uso terapêutico

Country Status (11)

Country Link
US (1) US20240182546A1 (pt)
EP (1) EP4313299A1 (pt)
JP (1) JP2024511604A (pt)
KR (1) KR20230159865A (pt)
CN (1) CN117120466A (pt)
AU (1) AU2022241942A1 (pt)
BR (1) BR112023019488A2 (pt)
CA (1) CA3212264A1 (pt)
DE (1) DE102021202830A1 (pt)
MX (1) MX2023011172A (pt)
WO (1) WO2022200422A1 (pt)

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399347A (en) 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen
US5593859A (en) 1991-10-23 1997-01-14 Thomas Jefferson University Synthesis of human procollagens and collagens in recombinant DNA systems
ES2143478T5 (es) 1991-10-23 2006-05-16 Thomas Jefferson University Sintesis de procolagenos y colagenos humanos en sistemas de adn de recombinacion.
US5529786A (en) 1994-02-28 1996-06-25 Moore; Eugene R. Process and product for treatment of rheumatoid arthritis
US5645851A (en) 1994-02-28 1997-07-08 Moore; Eugene R. Product for alleviating the symptons of arthritis in mammals
US5750144A (en) 1994-02-28 1998-05-12 Moore; Eugene R. Method for alleviating the symptoms of arthritis in mammals
US5637321A (en) 1994-02-28 1997-06-10 Moore; Eugene R. Method for preparing animal tissue for use in alleviating the symptoms of arthritis in mammals
CA2224709C (en) * 1995-06-13 2009-05-12 Nippon Meat Packers, Inc. Oral drugs and functional foods for treating and preventing rheumatoid arthritis
AU1593001A (en) 1999-11-12 2001-06-06 Fibrogen, Inc. Recombinant gelatin in vaccines
US7083820B2 (en) 2000-09-29 2006-08-01 Schilling Marvin L Method for producing biologically active products
CN1500876A (zh) * 2002-11-14 2004-06-02 �й������ž�����ҽѧ��ѧԺ����ҽ 一种编码鸡ⅱ型胶原蛋白的全长多核苷酸序列及其用途
EP1605862A4 (en) 2003-02-28 2008-09-03 Fibrogen Inc COLLAGEN COMPOSITIONS AND BIOMATERIALS
US20050058703A1 (en) 2003-08-01 2005-03-17 Chang Robert C. Gelatin capsules
WO2005106495A1 (en) * 2004-05-04 2005-11-10 Pharmacia & Upjohn Company Llc Procollagen ii biomarkers and methods
US20060100138A1 (en) 2004-11-10 2006-05-11 Olsen David R Implantable collagen compositions
US20080081353A1 (en) 2006-09-29 2008-04-03 Universite Laval Production of recombinant human collagen
DE102010060564A1 (de) 2010-11-15 2012-05-16 Gelita Ag Verwendung von Kollagenhydrolysat zur Verbesserung der Gesundheit der menschlichen Haut, Haare und/oder Nägel
DE102011000997A1 (de) 2011-03-01 2012-09-06 Gelita Ag Zusammensetzung für Ernährungszwecke
WO2014070796A1 (en) * 2012-10-29 2014-05-08 Scripps Health Methods of transplanting chondrocytes
DE102019202606A1 (de) * 2018-11-06 2020-05-07 Gelita Ag Rekombinante Herstellung eines Kollagenpeptidpräparates und dessen Verwendung

Also Published As

Publication number Publication date
AU2022241942A1 (en) 2023-10-12
DE102021202830A1 (de) 2022-09-29
WO2022200422A1 (de) 2022-09-29
US20240182546A1 (en) 2024-06-06
AU2022241942A9 (en) 2023-10-26
JP2024511604A (ja) 2024-03-14
KR20230159865A (ko) 2023-11-22
CN117120466A (zh) 2023-11-24
CA3212264A1 (en) 2022-09-29
EP4313299A1 (de) 2024-02-07
MX2023011172A (es) 2023-09-29

Similar Documents

Publication Publication Date Title
CY1113394T1 (el) Αντισωματα toy pan-kir2dl νκ υποδοχεα και η χρηση τους στη διαγνωση και τη θεραπεια
BRPI0912411B8 (pt) uso de uma muteína de interleucina humana-2 (muteína de hil-2) e composição farmacêutica para o tratamento e/ou profilaxia de uma doença autoimune
EA201101518A1 (ru) Фармацевтическая композиция для применения в медицинской и ветеринарной офтальмологии
BR112014026744A8 (pt) anticorpo isolado ou fragmento de anticorpo, composição de anticorpo ou composição de fragmento de anticorpo, uso de modulação imune, uso de pelo menos uma composição de anticorpo ou fragmento de anticorpo, dispositivo médico, formulação, kit, artigo de fabricação para uso farmacêutico humano, método para produzir um anticorpo ou fragmento, animal ou planta transgênica, e, anticorpo ou porção ou variante especificada.
BR112021013415A2 (pt) Proteínas de fusão multifuncionais e usos das mesmas
EP3960186A3 (en) Promoting bone health and repair and treating disorders related to collagen and pertinent proteins by using shilajit
MX2021007434A (es) Peptidos de colageno producidos de forma sintetica y recombinante con eficacia biologica.
BR112021026369A2 (pt) Derivados de 2h-indazol e seu uso no tratamento de doenças
BR112022004397A2 (pt) Composições para tratamento bucal que compreendem beta ácidos de lúpulo e aminoácidos
BR112015006656A8 (pt) composições e métodos para o tratamento de insuficiência cardíaca em pacientes diabéticos
BR112021015751A2 (pt) Vetores de terapia genética para tratamento da doença de danon
BR112019006174A2 (pt) proteina terapêutica
López et al. Platelet-rich plasma as an adjunctive therapy for the management of a severe chronic distal limb wound in a foal
MX2021012579A (es) Composiciones farmaceuticas a base de peptidos de colageno y dispositivos y metodos de produccion y uso de los mismos.
CL2021003312A1 (es) Composición que comprende pridopidina y un análogo de la misma para el tratamiento de la enfermedad de huntington y síntomas de la misma.
MX2009007550A (es) Polipeptidos naturales para el cuidado de la salud oral.
BR112015011099A2 (pt) Composições e métodos para o tratamento de diplasia ectodérmica
BR112023019488A2 (pt) Colágeno tipo ii recombinante para uso terapêutico
EA201791895A1 (ru) Дозы и способы введения телаванцина
BR112022020438A2 (pt) Composições compreendendo três proteínas de fusão ospa para uso médico
BRPI0418764B8 (pt) uso de espinosina, ou de um derivado ou sal fisiologicamente aceitável da mesma, na preparação de medicamentos para promover ou acelerar a cura de ferimento em um ser humano
RU2015153242A (ru) Действующее вещество для лечения саркопении
CY1108991T1 (el) Μεθοδος επουλωσης τραυματων με τη χορηγηση ανθρωπινης il-18
BR112015013215A2 (pt) proteína slurp-1 para uso na fabricação de medicamentos para o tratamento de doenças oculares
WO2019055776A3 (en) Compositions and methods for treatment of diseases involving cxcl1 function